Cohort Named Patient Program in United Arab Emirates

About Cohort Named Patient Program

Structured NPP for groups of patients sharing a common indication.

How Cohort Named Patient Program works in United Arab Emirates

The UAE recognises a formal Named Patient / compassionate-use pathway via MOHAP and the Department of Health Abu Dhabi (DoH). Physicians apply on behalf of individual patients for drugs not registered in-country.

Patients in United Arab Emirates seeking access under Cohort Named Patient Program typically follow this flow: a licensed physician in United Arab Emirates issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.

Documents required in United Arab Emirates

• Physician prescription and clinical-justification letter.
• Patient identification and consent.
• Country-specific NPP/personal-import form.
• Hospital or clinic attestation where required.

Typical timeline

End-to-end 2-6 weeks in most tier 1 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.

Start a request

Start a request under Cohort Named Patient Program in United Arab Emirates